Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10806325rdf:typepubmed:Citationlld:pubmed
pubmed-article:10806325lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:10806325lifeskim:mentionsumls-concept:C0017636lld:lifeskim
pubmed-article:10806325lifeskim:mentionsumls-concept:C0021764lld:lifeskim
pubmed-article:10806325lifeskim:mentionsumls-concept:C0001480lld:lifeskim
pubmed-article:10806325lifeskim:mentionsumls-concept:C0001721lld:lifeskim
pubmed-article:10806325lifeskim:mentionsumls-concept:C0030685lld:lifeskim
pubmed-article:10806325lifeskim:mentionsumls-concept:C0680255lld:lifeskim
pubmed-article:10806325lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:10806325lifeskim:mentionsumls-concept:C1283071lld:lifeskim
pubmed-article:10806325lifeskim:mentionsumls-concept:C1963578lld:lifeskim
pubmed-article:10806325lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:10806325pubmed:issue3lld:pubmed
pubmed-article:10806325pubmed:dateCreated2000-8-1lld:pubmed
pubmed-article:10806325pubmed:abstractTextT98G glioblastoma cells were previously shown to significantly increase interleukin-1beta (IL-1beta) mRNA levels in response to IL-1beta stimulation. This work demonstrates that in such conditions T98G, despite possessing biologically active interleukin converting enzyme, do not release detectable amounts of IL-1beta, even in the presence of 20 mM adenosine triphosphate (ATP). IL-1beta secretion is observed only following concomitant stimulation with 1000 units/ml of IL-1beta and 20 mM ATP. ATP induces a dose-dependent depolarization of T98G plasma membrane, whereas it does not affect Ca(2+) concentration or cell membrane permeability. Our data, together with the observation that the depolarizing effects of ATP are retained after preincubation with 100 microM suramin, an antagonist of P2-purinoceptors, suggest that ATP plays a role in IL-1beta secretion by T98G but its effects do not occur through P2-purinoceptors.lld:pubmed
pubmed-article:10806325pubmed:languageenglld:pubmed
pubmed-article:10806325pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10806325pubmed:citationSubsetIMlld:pubmed
pubmed-article:10806325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10806325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10806325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10806325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10806325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10806325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10806325pubmed:statusMEDLINElld:pubmed
pubmed-article:10806325pubmed:monthMaylld:pubmed
pubmed-article:10806325pubmed:issn0304-3940lld:pubmed
pubmed-article:10806325pubmed:authorpubmed-author:LetoSSlld:pubmed
pubmed-article:10806325pubmed:authorpubmed-author:MilanesiGGlld:pubmed
pubmed-article:10806325pubmed:authorpubmed-author:RuggieriAAlld:pubmed
pubmed-article:10806325pubmed:authorpubmed-author:PinzaMMlld:pubmed
pubmed-article:10806325pubmed:authorpubmed-author:ManganoGGlld:pubmed
pubmed-article:10806325pubmed:authorpubmed-author:SoldoLLlld:pubmed
pubmed-article:10806325pubmed:authorpubmed-author:PolenzaniLLlld:pubmed
pubmed-article:10806325pubmed:authorpubmed-author:ManciniFFlld:pubmed
pubmed-article:10806325pubmed:authorpubmed-author:LandolfiCClld:pubmed
pubmed-article:10806325pubmed:authorpubmed-author:de JoannonA...lld:pubmed
pubmed-article:10806325pubmed:issnTypePrintlld:pubmed
pubmed-article:10806325pubmed:day19lld:pubmed
pubmed-article:10806325pubmed:volume285lld:pubmed
pubmed-article:10806325pubmed:ownerNLMlld:pubmed
pubmed-article:10806325pubmed:authorsCompleteYlld:pubmed
pubmed-article:10806325pubmed:pagination218-22lld:pubmed
pubmed-article:10806325pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:10806325pubmed:meshHeadingpubmed-meshheading:10806325...lld:pubmed
pubmed-article:10806325pubmed:meshHeadingpubmed-meshheading:10806325...lld:pubmed
pubmed-article:10806325pubmed:meshHeadingpubmed-meshheading:10806325...lld:pubmed
pubmed-article:10806325pubmed:meshHeadingpubmed-meshheading:10806325...lld:pubmed
pubmed-article:10806325pubmed:meshHeadingpubmed-meshheading:10806325...lld:pubmed
pubmed-article:10806325pubmed:meshHeadingpubmed-meshheading:10806325...lld:pubmed
pubmed-article:10806325pubmed:meshHeadingpubmed-meshheading:10806325...lld:pubmed
pubmed-article:10806325pubmed:meshHeadingpubmed-meshheading:10806325...lld:pubmed
pubmed-article:10806325pubmed:meshHeadingpubmed-meshheading:10806325...lld:pubmed
pubmed-article:10806325pubmed:meshHeadingpubmed-meshheading:10806325...lld:pubmed
pubmed-article:10806325pubmed:meshHeadingpubmed-meshheading:10806325...lld:pubmed
pubmed-article:10806325pubmed:year2000lld:pubmed
pubmed-article:10806325pubmed:articleTitleAdenosine triphosphate affects interleukin -1beta release by T98G glioblastoma cells through a purinoceptor-independent mechanism.lld:pubmed
pubmed-article:10806325pubmed:affiliationA.C.R.A.F. - Angelini Ricerche, Piazzale della Stazione snc, 00040 Santa Palomba-Pomezia, Rome, Italy.lld:pubmed
pubmed-article:10806325pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10806325pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10806325lld:pubmed